Reboxetine
Reboxetine is a drug marketed as an antidepressant for use in the treatment of clinical depression, panic disorder and ADD/ADHD, developed by Pharmacia (now Pfizer).
ReboxetineVestraAntidepressantFluoxetineSertralineDiscovery and development of dual serotonin and norepinephrine reuptake inhibitorsNorepinephrine reuptake inhibitorEsreboxetineSecond-generation antidepressantC19H23NO3List of adrenergic drugsDavid Healy (psychiatrist)Attention deficit hyperactivity disorder managementInstitute for Quality and Efficiency in Health CareList of psychiatric medications by condition treatedNorepinephrine transporterSerotonin–norepinephrine–dopamine reuptake inhibitorCYP3A4LortalamineList of antidepressants
Share this!